Body

Study shows extreme form of pregnancy-related morning sickness could be genetic

Approximately 60,000 pregnant women are hospitalized each year due to hyperemesis gravidarum (HG), an extreme form of nausea and vomiting that endangers their lives and often forces them to reluctantly terminate their pregnancies.

And for women with sisters, mothers and grandmothers on either side of the family who have experienced extreme morning sickness during pregnancy, the risk of HG may be heightened, according to a new study led by researchers from UCLA and the University of Southern California.

Human-specific evolution in battling bugs and building babies

Although human and chimpanzee immune systems have many identical components, this is not the case for the family of killer cell immunoglobulin-like receptors (KIR) controlling white blood cells known as natural killer (NK) cells. Published in the open-access journal PloS Genetics on November 4, a paper by Stanford University researchers describes qualitative KIR differences, acquired after humans and chimpanzees separated 6 million years ago and mainly a consequence of innovation in the human line.

Health registry could transform chronic kidney disease care

A registry of health care information on patients with mild to moderate chronic kidney disease (CKD) could help physicians improve care for affected individuals, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that officials could use such a registry to develop a national surveillance system to identify and track various aspects of CKD.

We've come a long way, researchers: How a decade of research is helping lupus patients

Today, individuals with lupus nephritis benefit from better treatments than a decade ago, according to a review appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The article suggests that patients with the disease can now live full lives without suffering from many treatment-related side effects that plagued them in the past. In the future, patients will likely experience additional benefits from treatment strategies currently being explored in clinical trials.

Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic women

Lasofoxifene statistically reduced the overall risk of breast cancer, as well as ER positive invasive breast cancer in postmenopausal women with low bone density, according to a study published online in The Journal of the National Cancer Institute.

UC doctoral student presents research at international conference

Clement Loo, a University of Cincinnati doctoral student in the philosophy program, was one of the featured researchers at the biennial meeting of the Philosophy of Science Association Nov. 4-6 in Montreal, Quebec. The association promotes research, teaching and free discussion of issues in the philosophy of science.

Loo presented research themed around a Nov. 4 session on biology, evolution and selection. His paper was titled, "Invasive Species and Evaluating the Relative Significance of the Shifting Balance Theory."

Food-allergy fears drive overly restrictive diets

Many children, especially those with eczema, are unnecessarily avoiding foods based on incomplete information about potential food-allergies, according to researchers at National Jewish Health. The food avoidance poses a nutritional risk for these children, and is often based primarily on data from blood tests known as serum immunoassays.

Discovery shows promise against severe side effects

November 4, 2010 – (BRONX, NY) -- A team of scientists has found a way to eliminate a debilitating side effect associated with one of the main chemotherapy drugs used for treating colon cancer. The strategy used in their preclinical research—inhibiting an enzyme in bacteria of the digestive tract—could allow patients to receive higher and more effective doses of the drug, known as CPT-11 or Irinotecan.

Update on cancer vaccine research

Researchers at the University of Cambridge hope to revolutionise cancer therapy after discovering one of the reasons why many previous attempts to harness the immune system to treat cancerous tumours have failed.

Gene identified for spread of deadly melanoma

Gene identified for spread of deadly melanoma

Researchers at Washington University School of Medicine in St. Louis have identified a gene linked to the spread of eye melanoma.

Although more research is needed, the researchers say the discovery is an important step in understanding why some tumors spread (metastasize) and others don't. They believe the findings could lead to more effective treatments.

No easy solution to genetic 'battle of the sexes'

No easy solution to genetic 'battle of the sexes'

A new study published today shows a genetic 'battle of the sexes' could be much harder to resolve and even more important to evolution than previously thought.

Stem cells on a diet- how they respond to nutrient availability

Stem cells on a diet- how they respond to nutrient availability

LA JOLLA, CA—A study by researchers at the Salk Institute for Biological Studies revealed that stem cells can sense a decrease in available nutrients and respond by retaining only a small pool of active stem cells for tissue maintenance. When, or if, favorable conditions return, stem cell numbers multiply to accommodate increased demands on the tissue.

Helical CT scans reduce lung cancer mortality by 20 percent compared to chest X-rays

PROVIDENCE, R.I. [Brown University] — In a major new study announced today by the National Cancer Institute, researchers including Brown University biostatistian Constantine Gatsonis and his colleagues found that screening for lung cancer using helical CT scanning reduced lung cancer deaths by 20 percent compared to using chest X-rays.

Discovery blocks cancer drug's toxic side effect

A debilitating side effect of a widely used but harshly potent treatment for colon cancer could be eliminated if a promising new laboratory discovery bears fruit.

The pre-clinical finding, published in the Nov. 5, 2010, issue of the journal Science, relates to the drug CPT-11, or Irinotecan, a chemotherapeutic agent used against colon cancer and other solid malignancies. It is believed to be the first successful targeting of an enzyme in symbiotic bacteria found in the digestive system.

To prevent inbreeding, flowering plants have evolved multiple genes, research reveals

To prevent inbreeding, flowering plants have evolved multiple genes, research reveals